Clozapine N-oxide
SIGMA/C0832
Synonym: 8-
CAS Number: 34233-69-7
Empirical Formula (Hill Notation): C18H19ClN4O
Molecular Weight: 342.82
MDL Number: MFCD00210190
Linear Formula: C18H19ClN4O
Product Type: Chemical
| form | solid |
| InChI | 1S/C18H19ClN4O/c1-23(24)1 |
| InChI key | OGUCZBIQSYYWEF-UHFFFAOYSA |
| Quality Level | 200 ![]() |
| SMILES string | C[N+]1([O-])CCN(CC1)C2=Nc |
| Application: | Clozapine N-oxide has been used: • for the activation of human M4 muscarinic (hM4Di) in primary motor cortex • for inducing in vivo chemogenetic manipulation and impairing locomotor activity in Th-cre transgenic mice • in behavioral testing in mice and for stimulating (HEK293) cells |
| Biochem/physiol Actions: | 5-HT2 serotonin receptor antagonist; major metabolite of clopazine that can be monitored by HPLC. |
| Biochem/physiol Actions: | 5-HT2 serotonin receptor antagonist; major metabolite of clopazine. |
| Features and Benefits: | This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| General description: | Clozapine N-oxide (CNO), inactive from of clozapine drug, activates G-protein-coupled receptors (GPCRs). CNO serves as a synthetic ligand for engineered human muscarinic receptor. It elicits clozapine-like effects upon metabolic conversion. Clozapine conversion to CNO favors its passage through blood-brain barrier. |
| Packaging: | 5 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 - H336 |
| Precautionary statements | P301 + P310 + P330 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352119 |


